Unlock Neuroprotective Potential: Understanding 4-(4-(cyclopentyloxy)quinolin-2-yl)benzene-1,2-diol (CMS-121)

Discover the groundbreaking research behind CMS-121, a potent ACC1 inhibitor with significant neuroprotective and anti-aging properties, offering new avenues for combating age-related diseases.

Get a Quote & Sample

Advantages of Using CMS-121

Advanced Neuroprotection

CMS-121 exhibits strong neuroprotective properties, safeguarding neuronal cells against ischemia and oxidative damage, making it a key compound for researching neurodegenerative diseases.

Modulating Aging Processes

Studies show CMS-121 can reduce cognitive decline and metabolic markers associated with aging, highlighting its potential in promoting healthier aging.

Potent ACC1 Inhibition

As a potent inhibitor of Acetyl-CoA Carboxylase 1 (ACC1), CMS-121 offers a unique mechanism for modulating lipid metabolism and cellular energy, a critical aspect of many disease states.

Key Applications

Neuroscience Research

Investigate the CMS-121 mechanism of action in models of neurodegeneration and cognitive decline.

Aging Research

Utilize CMS-121 to explore strategies for mitigating age-related diseases and improving healthspan.

Drug Discovery & Development

Employ CMS-121 as a lead compound or research tool in the development of new therapeutics targeting metabolic and neurological disorders.

Biochemical Studies

Study the role of ACC1 inhibition and its downstream effects on cellular metabolism and signaling pathways.